RECRUITING

Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis

Talk to us

Conditions

Arthritis, RheumatoidRheumatoid arthritis

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this feasibility study is to determine if a new emerging technology called photoacoustic tomography (PAT) can be adapted for use in humans for the detection of chronic rheumatoid arthritis.

Official Title

Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis

Quick Facts

Study Start:2011-12-01
Study Completion:2027-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT00748254

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Men and women 18 years of age or older can participate in this study.
  2. * Patients can participate in this study if they have had rheumatoid arthritis for more than 2 years and their rheumatologist has referred them to this study.
  3. * Patients can participate as a healthy volunteer with a known history of rheumatoid arthritis.
  1. * Patients, who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prostheses or implanted neurological stimulator.
  2. * Pregnant patients.
  3. * Patients who is claustrophobic.
  4. * Patients with impaired renal function cannot participate in this study such as elevate creatinine clearance, patients on kidney dialysis etc.
  5. * Patients with shock hypotension or unstable low blood pressure.
  6. * Patients with Rhabdomyolysis.
  7. * Patients who have had a contrast enhanced (with gadolinium) MRA (magnetic resonance angiography)/ or MRI within the last 3 months. (Contrast is a medication injected into a vein during a imaging examination that helps produce clearer images/pictures).

Contacts and Locations

Study Contact

Safa Mohamed
CONTACT
734 615-1646
safam@med.umich.edu

Principal Investigator

Xueding Wang, Ph.D
PRINCIPAL_INVESTIGATOR
University of Michigan

Study Locations (Sites)

Universtity of Michigan Health System
Ann Arbor, Michigan, 48109
United States

Collaborators and Investigators

Sponsor: University of Michigan

  • Xueding Wang, Ph.D, PRINCIPAL_INVESTIGATOR, University of Michigan

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2011-12-01
Study Completion Date2027-01

Study Record Updates

Study Start Date2011-12-01
Study Completion Date2027-01

Terms related to this study

Keywords Provided by Researchers

  • Rheumatoid arthritis

Additional Relevant MeSH Terms

  • Arthritis, Rheumatoid